Abstract\nThe most widely used modality in pediatric cancer therapy is chemotherapy. The leukemias that occur in childhood usually are managed with chemotherapy alone. [1,2,10] Despite of a good therapeutic result, antineoplastic chemotherapy continues to be quite aggressive in children having neoplastic diseases.[1] Our study focused on the surveillance of toxicity of antineoplastic chemotherapy on 42 children between the ages of 3 and 18, with different stages of cancer. The statistical evaluation was carried out by chi square test. The most patients were diagnosed with acute lymphoblastic leukemia (22 cases; 52.4%). The rest of the patients were diagnosed with Ewing’s sarcoma (9 cases, 21.4%), Hodgkin lymphoma (7 cases, 16.7%), osteosarcoma (3 cases, 7.1%), and non-Hodgkin lymphoma (1 case, 2.4%). The toxicity level, on a scale of 0 to 4, appears very high in the case of leukopenia (level 4, under 1000/mm3), in the case of anemia (level 4, below 6.5 g/dL), and in the case of granulocytopenia (level 4, below 55/mm3). By strict and standard monitoring of the adverse side effects of antineoplastic chemotherapy, certain correlations can be made regarding a higher or lower toxicity level of certain therapeutic regimens.